MIST: Milestone Pharmaceuticals Inc

1.49 USD 0.04 (2.61%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de MIST a changé de -2.61% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 1.47 et à un maximum de 1.53.

Suivez la dynamique Milestone Pharmaceuticals Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

MIST Nouvelles

Seeking Alpha 18:16 Milestone Pharmaceuticals Remains A Buying Opportunity Despite Recent Dilution (MIST)
TipRanks 01:23 Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today? - TipRanks.com
Investing 20:30 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.63%
Benzinga 18:37 Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge - Federal Agricultural (NYSE:AGM), MiNK Therapeutics (NASDAQ:INKT)
Benzinga 16:22 Why Is Milestone Pharmaceuticals Stock Plunging On Friday? - Milestone Pharmaceuticals (NASDAQ:MIST)
TipRanks 15:52 Morning News Wrap-Up: Friday’s Biggest Stock Market Stories! - TipRanks.com
Benzinga 14:41 Dow Dips Over 200 Points; Levi Strauss Posts Upbeat Earnings - Concorde Intl Gr (NASDAQ:CIGL), Above Food Ingredients (NASDAQ:ABVE)
Investing 13:41 Milestone Pharmaceuticals prices $52.5 million public offering
Investing 12:54 Milestone Pharmaceuticals stock plunges on public offering announcement
Investing 10:05 FDA sets December 13 action date for Milestone’s CARDAMYST
Investing 10:04 Milestone Pharmaceuticals announces public offering of shares and warrants
Seeking Alpha 14:01 Watch Milestone Pharmaceuticals For (Likely) Upcoming FDA Approval For Cardamyst (MIST)
Investing 11:29 Milestone Pharmaceuticals resubmits Cardamyst filing after FDA response
Investing 12:09 Milestone Pharmaceuticals submits response to FDA for PSVT drug
Investing 12:32 Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Seeking Alpha 14:26 Milestone Pharmaceuticals: Opportunity To Buy On Etripamil's CRL In PSVT
Seeking Alpha 18:30 Stock Picks From Seeking Alpha's March 2025 New Analysts
Benzinga 16:14 Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher - AAR (NYSE:AIR), Abacus Global Management (NASDAQ:ABL)
Benzinga 13:58 Why Is Milestone Pharmaceuticals Stock Plunging Today? - Milestone Pharmaceuticals (NASDAQ:MIST)
Benzinga 13:41 Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected - Lexicon Pharmaceuticals (NASDAQ:LXRX), DBV Technologies (NASDAQ:DBVT)
Seeking Alpha 19:18 Milestone Pharmaceuticals: A Compelling Value Proposition For Patients And Payers

Range quotidien

1.47 1.53

Range Annuel

0.63 2.75

Clôture Précédente: 1.46
Ouverture: 1.53

Bid: 1.49
Ask: 1.79

Plus Bas: 1.47
Plus Haut: 1.53

Volume: 487

Changement quotidien: -2.61%
Changement Mensuel: -23.59%

Changement à 6 Mois: -23.59%
Changement Annuel: 2.05%

30 juillet, mercredi